Peyvandi F - Search Results

1

Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes.

de Haan HG, van Hylckama Vlieg A, Lotta LA, Gorski MM, Bucciarelli P, Martinelli I, Baglin TP, Peyvandi F, Rosendaal FR; INVENT consortium. de Haan HG, et al. Among authors: peyvandi f. J Thromb Haemost. 2018 Dec;16(12):2432-2441. doi: 10.1111/jth.14279. Epub 2018 Oct 16. J Thromb Haemost. 2018. PMID: 30168256 Free PMC article.

2

Frequency of factor V Arg506 Gln in Italians.

Mannucci PM, Duca F, Peyvandi F, Tagliabue L, Merati G, Martinelli I, Cattaneo M. Mannucci PM, et al. Among authors: peyvandi f. Thromb Haemost. 1996 Apr;75(4):694. Thromb Haemost. 1996. PMID: 8743202 No abstract available.

3

Rare coagulation disorders.

Peyvandi F, Mannucci PM. Peyvandi F, et al. Thromb Haemost. 1999 Oct;82(4):1207-14. Thromb Haemost. 1999. PMID: 10544899 Review.

4

A novel polymorphism in intron 1a of the human factor VII gene (G73A): study of a healthy Italian population and of 190 young survivors of myocardial infarction.

Peyvandi F, Mannucci PM, Bucciarelli P, Zeinali S, Akhavan S, Sacchi E, Merlini PA, Perry DJ. Peyvandi F, et al. Br J Haematol. 2000 Feb;108(2):247-53. doi: 10.1046/j.1365-2141.2000.01833.x. Br J Haematol. 2000. PMID: 10691850 Free article.

5

Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.

Mannucci PM, Bernardinelli L, Foco L, Galli M, Ribichini F, Tubaro M, Peyvandi F. Mannucci PM, et al. Among authors: peyvandi f. J Thromb Haemost. 2005 Feb;3(2):280-6. doi: 10.1111/j.1538-7836.2005.01116.x. J Thromb Haemost. 2005. PMID: 15670033 Free article.

6

Molecular characterization of an Italian patient with plasminogen deficiency and ligneous conjunctivitis.

Siboni SM, Spreafico M, Menegatti M, Martinelli I, Peyvandi F. Siboni SM, et al. Among authors: peyvandi f. Blood Coagul Fibrinolysis. 2007 Jan;18(1):81-4. doi: 10.1097/MBC.0b013e3280124f17. Blood Coagul Fibrinolysis. 2007. PMID: 17179833 Free article.

7

Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects.

Monaldini L, Asselta R, Duga S, Peyvandi F, Karimi M, Malcovati M, Tenchini ML. Monaldini L, et al. Among authors: peyvandi f. Thromb Haemost. 2007 Apr;97(4):546-51. Thromb Haemost. 2007. PMID: 17393016

8

Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.

Mannucci PM, Spreafico M, Peyvandi F. Mannucci PM, et al. Among authors: peyvandi f. J Thromb Haemost. 2008 Sep;6(9):1450-2. doi: 10.1111/j.1538-7836.2008.03073.x. Epub 2008 Jul 8. J Thromb Haemost. 2008. PMID: 18627441 Free article. No abstract available.

9

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy.

Spreafico M, Lodigiani C, van Leeuwen Y, Pizzotti D, Rota LL, Rosendaal F, Mannucci PM, Peyvandi F. Spreafico M, et al. Among authors: peyvandi f. Pharmacogenomics. 2008 Sep;9(9):1237-50. doi: 10.2217/14622416.9.9.1237. Pharmacogenomics. 2008. PMID: 18781852 Free article.

10

Inhibitors of factor VIII in hemophilia.

Peyvandi F, Lotta LA, Mannucci PM. Peyvandi F, et al. N Engl J Med. 2009 Jul 16;361(3):309; author reply 310. N Engl J Med. 2009. PMID: 19610162 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

731 results

Search Page